Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.
Latest website image capture
Clouds background image

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added and v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:29:51.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now shown in the page footer, replacing the previous label. The prior Revision: v3.4.3 label has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:42:53.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:27.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1, and the funding-status notice has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T01:57:52.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, indicating information may not be up to date and transactions may not be processed until appropriations are enacted, with guidance to check status on cc.nih.gov and opm.gov. Updated the page revision tag to v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-03T23:25:35.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added UI/metadata items Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:59:21.000Z thumbnail image

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.